These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 8442275)

  • 21. Immunological analysis of kidney allograft infiltrates during rejection: presence of cells coexpressing CD4 and CD8 antigens.
    Trovati A; Cinti P; Tamburro ML; Lattanzi R; Baiano V; Orlandini AM; Renna Molajoni E; Cortesini R
    Transplant Proc; 1995 Feb; 27(1):930-1. PubMed ID: 7879236
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunologic monitoring in OKT3-treated kidney graft recipients.
    Zlabinger GJ; Maurer D; Ulrich W; Meron G; Pohanka E; Kovarik J
    Transplant Proc; 1990 Aug; 22(4):1777-8. PubMed ID: 2117807
    [No Abstract]   [Full Text] [Related]  

  • 23. Anti-CD3 and -CD4 monoclonal antibody in the treatment of steroid-resistant renal allograft rejection.
    Wang XH; Xie T
    Chin Med J (Engl); 1993 Nov; 106(11):821-4. PubMed ID: 8143493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo-in vitro correlates of human rejection using flow cytometry with two-color fluorescence on peripheral blood mononuclear cells.
    Gross U; Thomas F; Matthews C; Thomas J; Cunningham P; Ritter T
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1609-10. PubMed ID: 2978885
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
    Woodle ES; Thistlethwaite JR; Haas M; Josephson MA; Newell KA; Bruce DS; Millis JM; Piper JB; Charette JI
    Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495
    [No Abstract]   [Full Text] [Related]  

  • 26. Depleting effect of antithymocyte globulin on T-lymphocyte subsets in kidney transplantation.
    Mestre M; Bas J; Alsina J; Grinyó JM; Buendia E
    Transplant Proc; 1999 Sep; 31(6):2254-5. PubMed ID: 10500565
    [No Abstract]   [Full Text] [Related]  

  • 27. OKT3 in severe early rejection: predictors for reversal in renal transplant recipients.
    Sumrani N; Delaney V; Rajpoot D; Tejani A; Butt K; Hong J
    Transplant Proc; 1990 Aug; 22(4):1750-2. PubMed ID: 2117797
    [No Abstract]   [Full Text] [Related]  

  • 28. Consequences of anti-OKT3 antibody development: OKT3 reuse and long-term graft survival.
    Shield CF
    Transplant Proc; 1993 Apr; 25(2 Suppl 1):81-2. PubMed ID: 8465434
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment with poly- and monoclonal antilymphocyte antibodies: assessment of efficacy and safety in transplantation.
    Claesson K; Tufveson G; Wahlberg J
    Transplant Proc; 1992 Feb; 24(1):314. PubMed ID: 1539293
    [No Abstract]   [Full Text] [Related]  

  • 30. Preliminary results of a prospectively randomized trial of ALG vs OKT3 for steroid-resistant rejection after renal transplantation in the early postoperative period.
    Hesse UJ; Wienand P; Baldamus C; Arns W
    Transplant Proc; 1990 Oct; 22(5):2273-4. PubMed ID: 2120814
    [No Abstract]   [Full Text] [Related]  

  • 31. Anti-B lymphocytotoxins in renal-allograft rejection.
    Ettenger RB; Terasaki PI; Ting A; Malekzadeh MH; Pennisi AJ; Uittenbogaart C; Garrison R; Fine RN
    N Engl J Med; 1976 Aug; 295(6):305-9. PubMed ID: 778617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serial changes in the expression of CXCR3 and CCR5 on peripheral blood lymphocytes following human renal transplantation.
    Inston N; Drayson M; Ready A; Cockwell P
    Exp Clin Transplant; 2007 Dec; 5(2):638-42. PubMed ID: 18194114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
    Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG
    Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
    [No Abstract]   [Full Text] [Related]  

  • 34. Prognostic significance of T cell associated surface antigen density changes during OKT3 therapy of renal allograft rejection.
    Shabtai M; Waltzer WC; Dominguez-Rafer C; Pullis CK; Malinowski K; Raisbeck AP; Rapaport FT
    J Urol; 1991 May; 145(5):928-31. PubMed ID: 1901920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphocyte propagation from biopsies of kidney allografts.
    Engstrand M; Larsson E; Naghibi M; Tufveson G; Korsgren O; Johnsson C
    Transpl Immunol; 2006 Nov; 16(3-4):215-9. PubMed ID: 17138056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cells infiltrating rejected human kidney allografts secrete IFN-gamma, IL-6, and IL-10, and are modulated by IL-2 and IL-4.
    Merville P; Pouteil-Noble C; Wijdenes J; Potaux L; Touraine JL; Banchereau J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):111-3. PubMed ID: 8438243
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of major histocompatibility complex matching on renal pathology and OKT4/OKT8 (CD4/CD8) ratio in renal allograft rejection.
    Smart YC; Nanra RS; Hibberd AD; Burton RC
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1627-8. PubMed ID: 3152632
    [No Abstract]   [Full Text] [Related]  

  • 38. OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine A.
    Widmer U; Frei D; Keusch G; Burger HR; Largiader F; Binswanger U
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):90-5. PubMed ID: 3140454
    [No Abstract]   [Full Text] [Related]  

  • 39. Mouse antibody-coated lymphocytes during OKT3 therapy in liver transplantation.
    Broughan TA; Valenzuela R; Escorcia E; Secic M; Vogt DP
    Clin Transplant; 1994 Oct; 8(5):488-91. PubMed ID: 7819617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring of ATG therapy by flow cytometry and lymphocyte counts in renal transplantation.
    Buchler M; Thibault G; al Najjar A; Valentin JF; Guerraoui A; Nivet H; Bardos P; Lebranchu Y
    Transplant Proc; 1996 Oct; 28(5):2817-8. PubMed ID: 8908076
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.